0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Myocardial Scar in Sarcoidosis by 12‐lead ECG and Pathology

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This case demonstrates the use of QRS scoring to quantify myocardial scar in a patient with cardiac sarcoidosis and left bundle branch block who progressively received an implantable defibrillator, cardiac resynchronization therapy (CRT), left ventricular assist device and cardiac transplantation. QRS scoring has been shown to correlate with magnetic resonance imaging measurements of scar, identify arrhythmogenic substrate and predict response to CRT, but had not previously been compared to pathology‐documented scar in nonischemic cardiomyopathies. Further study is warranted to assess the ability of QRS scoring to guide therapy for individual patients.

          Ann Noninvasive Electrocardiol 2011;16(2):219–222

          Related collections

          Author and article information

          Journal
          Ann Noninvasive Electrocardiol
          Ann Noninvasive Electrocardiol
          10.1111/(ISSN)1542-474X
          ANEC
          Annals of Noninvasive Electrocardiology : The Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
          Blackwell Publishing Inc (Malden, USA )
          1082-720X
          1542-474X
          18 April 2011
          April 2011
          : 16
          : 2 ( doiID: 10.1111/anec.2011.16.issue-2 )
          : 219-222
          Affiliations
          [ 1 ] From the *School of Medicine, Duke University, Durham, NC; *Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD; †Memorial Hospital Research Center, Long Beach, CA; and ‡Department of Pathology, Duke University, Durham, NC
          Author notes
          [*] Address for correspondence: David G. Strauss, M.D., PhD U.S. Food and Drug Administration 10903 New Hampshire Avenue WO66‐1305, Silver Spring, MD 20993. Fax: 240–331‐8884; E‐mail: david.strauss@ 123456fda.hhs.gov
          Article
          PMC6932549 PMC6932549 6932549 ANEC425
          10.1111/j.1542-474X.2011.00425.x
          6932549
          21496175
          9dc40689-2d77-4491-a384-5952ee2fad8a
          ©2011, Wiley Periodicals, Inc.
No claim to original US government works
          History
          Page count
          links-crossref: 13, Figures: 2, Tables: 0, Equations: 0, References: 4, Pages: 4
          Categories
          Case Reports
          Custom metadata
          2.0
          April 2011
          Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.3 mode:remove_FC converted:18.12.2019

          Clinical, electrophysiology ‐ ventricular tachycardia,clinical, implantable devices ‐ biventricular pacing/defibrillation,noninvasive techniques ‐ electrocardiography,clinical

          Comments

          Comment on this article